Thai Cancer Anemia Survey in Chulalongkorn Hospital
May 22, 2014 updated by: Janssen-Cilag Ltd.,Thailand
The purpose of this study is to create a large Thailand database documenting the severity of anemia and its management in the cancer population.
Study Overview
Detailed Description
Thai Cancer Anemia Study (TCAS) is a prospective survey that will track anemia management in an adult cancer population.
This survey is not intended to interfere with standard medical practices for handling anemia.
Information on laboratory values including target and achieved hemoglobin (Hb) levels during chemotherapy cycles, use of blood transfusions, iron supplementation, and epoetin will be collected in addition to information on cancer status and treatment.
Data on the level that triggers clinicians to decide on the need for anemia therapy will also be collected.
Each patient included in the survey will be followed for six months.
Observational Study - No investigational drug administered
Study Type
Observational
Enrollment (Actual)
264
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bangkok, Thailand
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Anemic patients with cancer receiving chemotherapy
Description
Inclusion Criteria:
- Patients with cancer
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
001
Adult Cancer Patients Tracking anemia management in Adult Cancer Patients
|
Tracking anemia management in Adult Cancer Patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of patients that have anemia during cancer therapy
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Characteristic of each patients example treatment duration,type and chemotherapy using, grade of anemia
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2006
Primary Completion (Actual)
December 1, 2009
Study Completion (Actual)
December 1, 2009
Study Registration Dates
First Submitted
November 19, 2009
First Submitted That Met QC Criteria
November 20, 2009
First Posted (Estimate)
November 23, 2009
Study Record Updates
Last Update Posted (Estimate)
May 23, 2014
Last Update Submitted That Met QC Criteria
May 22, 2014
Last Verified
May 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CR011731
- TCAS-CU-ONCO-2006
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.